hNIS-based imaging to monitor treatment with the novel oncolytic virus CF33-hNIS-antiPDL1 in humans with advanced triple negative breast cancer
Authors
- Hans Meisen
- Jamie Rand
- Shyambabu Chaurasiya (ORCID: https://orcid.org/0000-0002-9543-5458)
- Amanda Seiz
- Yuan Yuan (ORCID: https://orcid.org/0000-0001-6373-814X)
- Jianying Zhang (ORCID: https://orcid.org/0000-0001-5896-9509)
- Leslie Chong
- Yuman Fong
- Supriya Deshpande
- Dave Yamauchi
Institutions
- Cedars-Sinai Medical Center (US)
- City of Hope (US)
- Engeneic (Australia) (AU)